99 related articles for article (PubMed ID: 2224770)
21. Potential role of the inactivated X chromosome in ovarian epithelial tumor development.
Cheng PC; Gosewehr JA; Kim TM; Velicescu M; Wan M; Zheng J; Felix JC; Cofer KF; Luo P; Biela BH; Godorov G; Dubeau L
J Natl Cancer Inst; 1996 Apr; 88(8):510-8. PubMed ID: 8606379
[TBL] [Abstract][Full Text] [Related]
22. The retinoblastoma gene is involved in malignant progression of astrocytomas.
Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
[TBL] [Abstract][Full Text] [Related]
23. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.
Kelley MJ; Nakagawa K; Steinberg SM; Mulshine JL; Kamb A; Johnson BE
J Natl Cancer Inst; 1995 May; 87(10):756-61. PubMed ID: 7563154
[TBL] [Abstract][Full Text] [Related]
24. Absence of germline retinoblastoma (Rb) gene mutations in Japanese ovarian cancer patients.
Schehl CM; Ostrander GK
Gynecol Oncol; 1998 Sep; 70(3):440-1. PubMed ID: 9790804
[No Abstract] [Full Text] [Related]
25. Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization.
Stilgenbauer S; Leupolt E; Ohl S; Weiss G; Schröder M; Fischer K; Bentz M; Lichter P; Döhner H
Cancer Res; 1995 Aug; 55(16):3475-7. PubMed ID: 7627948
[TBL] [Abstract][Full Text] [Related]
26. Low frequency of retinoblastoma gene alterations in rat hepatocellular carcinomas.
Smith ML; Chandar N; Lombardi B
Mol Carcinog; 1993; 8(4):228-33. PubMed ID: 8280371
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma.
Walther MM; Gnarra JR; Elwood L; Xu HJ; Florence C; Anglard P; Hu SX; King C; Trahan E; Hurley K
J Urol; 1995 Jun; 153(6):2050-4. PubMed ID: 7752392
[TBL] [Abstract][Full Text] [Related]
28. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.
Cordon-Cardo C; Wartinger D; Petrylak D; Dalbagni G; Fair WR; Fuks Z; Reuter VE
J Natl Cancer Inst; 1992 Aug; 84(16):1251-6. PubMed ID: 1640484
[TBL] [Abstract][Full Text] [Related]
29. The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.
Borg A; Zhang QX; Alm P; Olsson H; Sellberg G
Cancer Res; 1992 May; 52(10):2991-4. PubMed ID: 1581913
[TBL] [Abstract][Full Text] [Related]
30. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
[TBL] [Abstract][Full Text] [Related]
31. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
32. Ploidy disturbances in endometrial and ovarian carcinomas. A review.
Iversen OE; Laerum OD
Anal Quant Cytol Histol; 1985 Dec; 7(4):327-36. PubMed ID: 3911973
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.
Thai TH; Du F; Tsan JT; Jin Y; Phung A; Spillman MA; Massa HF; Muller CY; Ashfaq R; Mathis JM; Miller DS; Trask BJ; Baer R; Bowcock AM
Hum Mol Genet; 1998 Feb; 7(2):195-202. PubMed ID: 9425226
[TBL] [Abstract][Full Text] [Related]
34. Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma.
Cao SN; Chang KH; Luthra R; Liu J
Mod Pathol; 2003 Oct; 16(10):1048-52. PubMed ID: 14559989
[TBL] [Abstract][Full Text] [Related]
35. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.
Wunder JS; Czitrom AA; Kandel R; Andrulis IL
J Natl Cancer Inst; 1991 Feb; 83(3):194-200. PubMed ID: 1988704
[TBL] [Abstract][Full Text] [Related]
36. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.
Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T
Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150
[TBL] [Abstract][Full Text] [Related]
37. Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants.
Bookstein R; Lee EY; To H; Young LJ; Sery TW; Hayes RC; Friedmann T; Lee WH
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2210-4. PubMed ID: 2895471
[TBL] [Abstract][Full Text] [Related]
38. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
39. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
40. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
